Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Therefore, the aim of this study was to evaluate the application of a commercial product containing 40% MGH (L-Mesitran Soft®) in improving ovarian tissue endothelial density after transplantation and comparing it with VEGF and vitamin D supplementation.

Source: 1. Introduction. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The rat model is more appropriate for tumor studies and postimplantation studies [,,].

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Medical Grade Honey as a Promising Treatment to Improve Ovarian Tissue Transplantation

Study design awaiting verification · Bioengineering · 2022

Original publication title

Medical Grade Honey as a Promising Treatment to Improve Ovarian Tissue Transplantation

Ana Rita Azevedo; Ana Sofia Pais; Teresa Almeida-Santos; Virgínia M. R. Pires; Pedro Pessa; Carla C. Marques; Sofia Nolasco; Pedro Castelo-Branco; José A. M. Prates; Luís Lopes-da-Costa; Mafalda Laranjo; Maria Filomena Botelho; Rosa M. L. N. Pereira; Jorge M. B. G. A. Pimenta

© 2022 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Ovarian tissue cryopreservation is a female fertility preservation technique that presents major challenges for the maintenance of follicular viability after transplantation. The aim of this study was to evaluate and compare the application of L-Mesitran Soft®, a product containing 40% medical grade honey (MGH), with other strategies to improve ovarian grafts’ viability. For this purpose, bovine ovarian tissue was vitrified, warmed and randomly assigned to culture groups: (1) control, (2) MGH 0.2% in vitro, (3) MGH in vivo (direct application in the xenotransplantation), (4) vascular endothelial growth factor (VEGF 50 ng/mL) and (5) vitamin D (100 Nm), during a 48 h period.

A sixth group (6) of fragments was thawed on transplantation day and was not cultured. The tissue was xenotransplanted into immunodeficient (Rowett nude homozygous) ovariectomized rats. Grafts were analyzed 48 h after culture, and 7 and 28 days after transplantation. The tissue was subjected to histological and immunohistochemical analysis. Treatments using MGH showed the highest angiogenic and cell proliferation stimulation, with cellular apoptosis, within a healthy cellular turnover pathway. In conclusion, MGH should be considered as a potentially effective and less expensive strategy to improve ovarian tissue transplantation.

Authors’ abstract

Ovarian tissue cryopreservation is a female fertility preservation technique that presents major challenges for the maintenance of follicular viability after transplantation. The aim of this study was to evaluate and compare the application of L-Mesitran Soft®, a product containing 40% medical grade honey (MGH), with other strategies to improve ovarian grafts’ viability. For this purpose, bovine ovarian tissue was vitrified, warmed and randomly assigned to culture groups: (1) control, (2) MGH 0.2% in vitro, (3) MGH in vivo (direct application in the xenotransplantation), (4) vascular endothelial growth factor (VEGF 50 ng/mL) and (5) vitamin D (100 Nm), during a 48 h period.

A sixth group (6) of fragments was thawed on transplantation day and was not cultured. The tissue was xenotransplanted into immunodeficient (Rowett nude homozygous) ovariectomized rats. Grafts were analyzed 48 h after culture, and 7 and 28 days after transplantation. The tissue was subjected to histological and immunohistochemical analysis. Treatments using MGH showed the highest angiogenic and cell proliferation stimulation, with cellular apoptosis, within a healthy cellular turnover pathway. In conclusion, MGH should be considered as a potentially effective and less expensive strategy to improve ovarian tissue transplantation.

Publication and source details

Original title: Medical Grade Honey as a Promising Treatment to Improve Ovarian Tissue Transplantation

Ana Rita Azevedo; Ana Sofia Pais; Teresa Almeida-Santos; Virgínia M. R. Pires; Pedro Pessa; Carla C. Marques; Sofia Nolasco; Pedro Castelo-Branco; José A. M. Prates; Luís Lopes-da-Costa; Mafalda Laranjo; Maria Filomena Botelho; Rosa M. L. N. Pereira; Jorge M. B. G. A. Pimenta

Bioengineering · 2022

* Correspondence: ana_rita_azevedo@hotmail.com
†

These authors contributed equally to this work.

© 2022 by the authors.2022https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).CIISAFCT UIDB-00276-2020Centro Hospitalar e Universitário de CoimbraSociedade Portuguesa de Ginecologia (SPG), Merck, SACSD006003Foundation for Science and Technology (FCT)UID/NEU/04539/2013UID/NEU/04539/2019COMPETE-FEDERPOCI-01-0145-FEDER-007440Fundação para a Ciência e a TecnologiaAL4AnimalSLA/P/0059/2020This research was funded by FCT UIDB-00276-2020 (CIISA); Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Sociedade Portuguesa de Ginecologia (SPG), Merck, SA (CSD006003);the Foundation for Science and Technology (FCT), Portugal (Strategic Projects UID/NEU/04539/2013 and UID/NEU/04539/2019), COMPETE-FEDER (POCI-01-0145-FEDER-007440) and Fundação para a Ciência e a Tecnologia, Portugal, through CIISA (UIDB/00276/2020) and AL4AnimalS (LA/P/0059/2020) grants.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T09:14:35.120694+00:00

DOI: 10.3390/bioengineering9080357 · PMC9405527